4.11
price up icon13.85%   0.50
after-market After Hours: 4.15 0.04 +0.97%
loading
Savara Inc stock is traded at $4.11, with a volume of 2.61M. It is up +13.85% in the last 24 hours and up +16.43% over the past month. Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
See More
Previous Close:
$3.61
Open:
$3.65
24h Volume:
2.61M
Relative Volume:
1.93
Market Cap:
$710.36M
Revenue:
-
Net Income/Loss:
$-54.70M
P/E Ratio:
-12.45
EPS:
-0.33
Net Cash Flow:
$-51.36M
1W Performance:
+20.53%
1M Performance:
+16.43%
6M Performance:
+36.54%
1Y Performance:
+9.31%
1-Day Range:
Value
$3.60
$4.12
1-Week Range:
Value
$3.36
$4.12
52-Week Range:
Value
$1.89
$4.295

Savara Inc Stock (SVRA) Company Profile

Name
Name
Savara Inc
Name
Phone
51285113796
Name
Address
6836 BEE CAVE ROAD, AUSTIN, TX
Name
Employee
59
Name
Twitter
@SavaraPharma
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
SVRA's Discussions on Twitter

Compare SVRA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SVRA
Savara Inc
4.11 623.94M 0 -54.70M -51.36M -0.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
419.10 106.87B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
491.22 63.14B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
576.77 61.27B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
849.46 51.94B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
167.91 35.04B 398.11M -1.03B -868.57M -5.7032

Savara Inc Stock (SVRA) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-15-25 Upgrade H.C. Wainwright Neutral → Buy
May-29-25 Downgrade H.C. Wainwright Buy → Neutral
Dec-20-24 Initiated Wells Fargo Overweight
Nov-13-24 Downgrade Evercore ISI Outperform → In-line
Feb-15-24 Initiated JMP Securities Mkt Outperform
Nov-07-23 Initiated Guggenheim Buy
May-16-23 Upgrade Jefferies Hold → Buy
Mar-31-23 Downgrade Jefferies Buy → Hold
Mar-16-21 Initiated Piper Sandler Overweight
Mar-15-21 Initiated Oppenheimer Outperform
Jun-13-19 Reiterated H.C. Wainwright Buy
Jun-13-19 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-13-19 Downgrade Ladenburg Thalmann Buy → Neutral
Aug-13-18 Resumed ROTH Capital Neutral
Jan-03-18 Initiated Ladenburg Thalmann Buy
Sep-27-17 Resumed ROTH Capital Buy
Sep-22-17 Initiated Jefferies Buy
Sep-11-17 Initiated JMP Securities Mkt Outperform
View All

Savara Inc Stock (SVRA) Latest News

pulisher
Oct 20, 2025

Aug EndMonth: How geopolitical risks impact Savara Inc. (YB4P) stockStop Loss & Weekly High Return Stock Forecasts - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Savara Inc. (SVRA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 7, 2025 Deadline - ACCESS Newswire

Oct 20, 2025
pulisher
Oct 20, 2025

Shareholders SueWallSt in New Class Action Against Savara Inc.Act Now - ACCESS Newswire

Oct 20, 2025
pulisher
Oct 20, 2025

How geopolitical risks impact Savara Inc. (YB4P) stockWeekly Investment Summary & Community Consensus Picks - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Levi & Korsinsky Reminds Savara Inc. Investors of the - GlobeNewswire

Oct 20, 2025
pulisher
Oct 20, 2025

Deadline Alert: Savara Inc. (SVRA) Shareholders Who Lost - GlobeNewswire

Oct 20, 2025
pulisher
Oct 20, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers – SVRA - FinancialContent

Oct 20, 2025
pulisher
Oct 20, 2025

Pattern recognition hints at Savara Inc. upsideWeekly Trading Summary & Verified Momentum Watchlists - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

SVRA Investors Have Opportunity to Lead Savara Inc. Securities F - GuruFocus

Oct 20, 2025
pulisher
Oct 20, 2025

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Oct 20, 2025
pulisher
Oct 20, 2025

Savara Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSVRA - MarketScreener

Oct 20, 2025
pulisher
Oct 19, 2025

Class Action Filed Against Savara Inc. (SVRA) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire

Oct 19, 2025
pulisher
Oct 19, 2025

Class Action Lawsuit Filed Against Savara Inc. (SVRA)Recover LossesContact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire

Oct 19, 2025
pulisher
Oct 18, 2025

Why Savara Inc. is moving todayGap Up & Verified Stock Trade Ideas - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Is Savara Inc. stock recession proofJuly 2025 Gainers & Community Verified Trade Signals - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

How analysts revise price targets for Savara Inc. (YB4P) stockJuly 2025 Technicals & High Accuracy Buy Signal Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges Savara, Inc. Investors to ... - Bluefield Daily Telegraph

Oct 18, 2025
pulisher
Oct 18, 2025

SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges Savara, Inc. Investors to Contact the Firm Before November 7th Deadline - GlobeNewswire Inc.

Oct 18, 2025
pulisher
Oct 18, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain OfficersSVRA - PR Newswire

Oct 18, 2025
pulisher
Oct 18, 2025

Rate Hike: How analysts revise price targets for Savara Inc. (YB4P) stockCPI Data & Pattern Based Trade Signal System - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Why Savara Inc. stock could benefit from AI revolutionTrade Ideas & Short-Term High Return Strategies - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Savara promotes Yasmine Wasfi to chief medical officer By Investing.com - Investing.com Nigeria

Oct 17, 2025
pulisher
Oct 17, 2025

SVRA Lead Plaintiff Deadline (11/7/25) Reminder: Savara - GlobeNewswire

Oct 17, 2025
pulisher
Oct 17, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire

Oct 17, 2025
pulisher
Oct 17, 2025

Q3 Earnings Forecast for Savara Issued By Lifesci Capital - Defense World

Oct 17, 2025
pulisher
Oct 17, 2025

Savara promotes Yasmine Wasfi to chief medical officer - Investing.com

Oct 17, 2025
pulisher
Oct 17, 2025

Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - cnhinews.com

Oct 17, 2025
pulisher
Oct 17, 2025

Savara promotes Wasfi to Chief Medical Officer - TipRanks

Oct 17, 2025
pulisher
Oct 17, 2025

Savara Announces Chief Medical Officer (CMO) Transition - The Joplin Globe

Oct 17, 2025
pulisher
Oct 16, 2025

Investors SueWallSt as Savara Inc. Faces Securities Fraud Allegations - ACCESS Newswire

Oct 16, 2025
pulisher
Oct 16, 2025

Faruqi & Faruqi Reminds Savara Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - FinancialContent

Oct 16, 2025
pulisher
Oct 16, 2025

SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Oct 16, 2025
pulisher
Oct 16, 2025

SVRA LAWSUIT ALERT: The Gross Law Firm Notifies Savara Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WV News

Oct 16, 2025
pulisher
Oct 16, 2025

SVRA Shareholders Have Opportunity to Lead Savara Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Oct 16, 2025
pulisher
Oct 16, 2025

SVRA DEADLINE ALERT: Savara Inc. Investors Encouraged to - GlobeNewswire

Oct 16, 2025
pulisher
Oct 15, 2025

SVRA DEADLINE ALERT: Savara Inc. Investors Encouraged to Contact Kirby McInerney LLP Before ... - Bluefield Daily Telegraph

Oct 15, 2025
pulisher
Oct 15, 2025

Savara Inc. (SVRA) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Oct 15, 2025
pulisher
Oct 15, 2025

Savara, Inc.: A Deep Dive (NASDAQ:SVRA) - Seeking Alpha

Oct 15, 2025
pulisher
Oct 15, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - Morningstar

Oct 15, 2025
pulisher
Oct 14, 2025

SAVARA DEADLINE REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire

Oct 14, 2025
pulisher
Oct 13, 2025

Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire

Oct 13, 2025
pulisher
Oct 13, 2025

Lost Money on Savara Inc. (SVRA)? Join Class Action Before November 7, 2025Contact Levi & Korsinsky - ACCESS Newswire

Oct 13, 2025
pulisher
Oct 13, 2025

November 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SVRA - MarketScreener

Oct 13, 2025
pulisher
Oct 12, 2025

Did You Lose Money on Savara Inc. (SVRA)? Levi & Korsinsky Urges Investors to Act Before November 7, 2025 - ACCESS Newswire

Oct 12, 2025
pulisher
Oct 12, 2025

Securities Lawsuit Alert: Savara Inc. (SVRA)Contact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire

Oct 12, 2025
pulisher
Oct 12, 2025

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit - PR Newswire

Oct 12, 2025
pulisher
Oct 12, 2025

Securities Fraud Class Action Filed Against Savara Inc. (SVRA)Levi & Korsinsky Reminds Investors of November 7, 2025 - ACCESS Newswire

Oct 12, 2025
pulisher
Oct 12, 2025

November 7, 2025 Deadline Approaching: Join Class Action Against Savara Inc. (SVRA)Contact Levi & Korsinsky - ACCESS Newswire

Oct 12, 2025
pulisher
Oct 12, 2025

SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire

Oct 12, 2025
pulisher
Oct 10, 2025

SAVARA ALERT: Bragar Eagel & Squire, P.C. Urges Investors - GlobeNewswire

Oct 10, 2025

Savara Inc Stock (SVRA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.63
price down icon 1.03%
$86.17
price down icon 1.60%
$30.54
price down icon 7.93%
$107.95
price up icon 2.67%
biotechnology ONC
$318.59
price up icon 0.69%
$167.91
price up icon 1.30%
Cap:     |  Volume (24h):